PU.1/Spi-B regulation of c-rel is essential for mature B cell survival

Immunity

Volumn 15, Issue 4, 2001, Pages 545-555

  Hu, Cheng Jun ^a,b   Rao, Sridhar ^c   Ramirez Bergeron, Diana L ^a,b   Garrett Sinha, Lee Ann ^c   Gerondakis, Steve ^d   Clark, Marcus R ^c   Simon, M Celeste ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING SITE; BONE MARROW; CELL COUNT; CELL MATURATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SPLEEN CELL;

EID: 0034748923     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00219-9     Document Type: Article

References (56)

1. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro
2. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage
3. The NF-kappa B and I kappa B proteins: New discoveries and insights
4. Spi-C, a novel Ets protein that is temporally regulated during B lymphocyte development
5. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L)
6. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B
7. PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer
8. Requirement for NF-kappaB in osteoclast and B-cell development
9. PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction
10. Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: Transgenics and knockouts
11. Transcription factors in lymphocyte development - T and B cells get together
12. The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects
13. The anti-apoptotic activities of rel and RelA required during B-cell maturation involve the regulation of bcl-2 expression
14. The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli
15. The subunit composition of NF-kappa B complexes changes during B-cell development
16. Rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells
17. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
18. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF- kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
19. Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus
20. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene
21. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites
22. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells
23. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1
24. Functional significance of alternate phosphorylation in Sendai virus P protein
25. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2
26. Induction of nuclear factor-kappa B during primary B cell differentiation
27. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
28. A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS- domain-DNA complex
29. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
30. Genetic analysis of B cell antigen receptor signaling
31. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
32. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation
33. The ets gene family
34. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation
35. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
36. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif
37. Differential interaction of nuclear factors with the leukocyte-specific pp52 promoter in B and T cells
38. Multiple motifs regulate the B-cell-specific promoter of the B29 gene
39. Production of high-titer helper-free retroviruses by transient transfection
40. Functional characterization of the developmentally controlled immunoglobulin kappa 3′ enhancer: Regulation by Id, a repressor of helix-loop-helix transcription factors
41. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity
42. Notch1 expression in early lymphopoiesis influences B versus T lineage determination
43. The Ets factors PU.1 and Spi-B regulate the transcription in vivo of P2Y10, a lymphoid restricted heptahelical receptor
44. SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1
45. Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1
46. DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter
47. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
48. Ets-related protein PU.1 regulates expression of the immunoglobulin J- chain gene through a novel Ets-binding element
49. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease
50. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B
51. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development
52. c-Rel is essential for B lymphocyte survival and cell cycle progression
53. Cloning and transcription factor-binding sites of the human c-rel proto-oncogene promoter
54. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen
55. Regulation of mouse CD72 gene expression during B lymphocyte development
56. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis